Table 1 Characteristics of included studies
From: Association of TCF4 polymorphisms and fuchs’ endothelial dystrophy: a meta-analysis
First Author (year) | Country | Ethnicity | Study design | Genotyping method | Case/Control | Source of control | SNP | HW-E test |
|---|---|---|---|---|---|---|---|---|
Baratz (2010)a [8] | USA | Caucasian | GWAS | Taqman assay | 130/260 | HB | rs613872,rs17595731, | yes |
rs9954153,rs2286812 | ||||||||
Baratz (2010)b [8] | USA | Caucasian | GWAS | Taqman assay | 150/150 | HB | rs613872,rs17595731, | yes |
rs9954153,rs2286812 | ||||||||
Li (2011) [23] | USA | Caucasian | Case–control | Taqman assay | 450/340 | HB | rs613872 | yes |
Riazuddin (2011) [24] | USA | Caucasian | Case–control | Taqman assay | 170/180 | HB | rs613872 | yes |
Thalamuthu (2011) [34] | Singapore | Asian | Case–control | MassArray | 57/121 | HB | rs2286812 | yes |
Igo (2012) [22] | USA | Caucasian | Case–control | Taqman assay | 531/204 | HB | rs613872 | no |
Kuot (2012) [16] | Australia | Caucasian | Case–control | MassArray | 103/275 | HB | rs613872,rs9954153, | yes |
rs2286812,rs17595731 | ||||||||
Stamler (2013) [15] | USA | Caucasian | Case–control | Taqman assay | 82/163 | HB | rs613872 | yes |
Nanda (2014) [17] | India | Asian | Case–control | PCR-sequencing | 44/108 | HB | rs613872 | yes |
Wang (2014) [35] | China | Asian | Case–control | Taqman assay | 34/491 | HB | rs2286812 | yes |
Li (2014) [19] | USA | Caucasian | Case–control | Taqman assay | 529/494 | HB | rs613872 | yes |
Mootha (2014) [13] | USA | Caucasian | Case–control | Taqman assay | 120/100 | HB | rs613872 | yes |
Wieben (2014) [25] | USA | Caucasian | Case–control | PCR-sequencing | 68/16 | HB | rs613872 | yes |